Premium
Interaction of cocaine‐, benztropine‐, and GBR12909‐like compounds with wild‐type and mutant human dopamine transporters: molecular features that differentially determine antagonist‐binding properties
Author(s) -
Schmitt Kyle C.,
Zhen Juan,
Kharkar Prashant,
Mishra Manoj,
Chen Nianhang,
Dutta Aloke K.,
Reith Maarten E. A.
Publication year - 2008
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.2008.05667.x
Subject(s) - benztropine , dopamine transporter , tropane , chemistry , dopamine plasma membrane transport proteins , transporter , dopamine , dopamine uptake inhibitors , stereochemistry , pharmacology , biochemistry , neuroscience , receptor , psychology , biology , gene , nucleus accumbens
The widely abused psychostimulant cocaine is thought to elicit its reinforcing effects primarily via inhibition of the neuronal dopamine transporter (DAT). However, not all DAT inhibitors share cocaine’s behavioral profile, despite similar or greater affinity for the DAT. This may be due to differential molecular interactions with the DAT. Our previous work using transporter mutants with altered conformational equilibrium (W84L and D313N) indicated that benztropine and GBR12909 interact with the DAT in a different manner than cocaine. Here, we expand upon these previous findings, studying a number of structurally different DAT inhibitors for their ability to inhibit [ 3 H]CFT binding to wild‐type, W84L and D313N transporters. We systematically tested structural intermediates between cocaine and benztropine, structural hybrids of benztropine and GBR12909 and a number of other structurally heterologous inhibitors. Derivatives of the stimulant desoxypipradrol (2‐benzhydrylpiperidine) exhibited a cocaine‐like binding profile with respect to mutation, whereas compounds possessing the diphenylmethoxy moiety of benztropine and GBR12909 were dissimilar to cocaine‐like compounds. In tests with specific isomers of cocaine and tropane analogues, compounds with 3α stereochemistry tended to exhibit benztropine‐like binding, whereas those with 3β stereochemistry were more cocaine‐like. Our results point to the importance of specific molecular features – most notably the presence of a diphenylmethoxy moiety – in determining a compound’s binding profile. This study furthers the concept of using DAT mutants to differentiate cocaine‐like inhibitors from atypical inhibitors in vitro . Further studies of the molecular features that define inhibitor–transporter interaction could lead to the development of DAT inhibitors with differential clinical utility.